336 related articles for article (PubMed ID: 12612067)
1. Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity.
Schaaf MJ; Cidlowski JA
Mol Cell Biol; 2003 Mar; 23(6):1922-34. PubMed ID: 12612067
[TBL] [Abstract][Full Text] [Related]
2. Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active.
Lewis-Tuffin LJ; Jewell CM; Bienstock RJ; Collins JB; Cidlowski JA
Mol Cell Biol; 2007 Mar; 27(6):2266-82. PubMed ID: 17242213
[TBL] [Abstract][Full Text] [Related]
3. Ligand-selective targeting of the glucocorticoid receptor to nuclear subdomains is associated with decreased receptor mobility.
Schaaf MJ; Lewis-Tuffin LJ; Cidlowski JA
Mol Endocrinol; 2005 Jun; 19(6):1501-15. PubMed ID: 15705660
[TBL] [Abstract][Full Text] [Related]
4. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.
Wallace AD; Cidlowski JA
J Biol Chem; 2001 Nov; 276(46):42714-21. PubMed ID: 11555652
[TBL] [Abstract][Full Text] [Related]
5. Phenylalanine-780 near the C-terminus of the mouse glucocorticoid receptor is important for ligand binding affinity and specificity.
Chen D; Kohli K; Zhang S; Danielsen M; Stallcup MR
Mol Endocrinol; 1994 Apr; 8(4):422-30. PubMed ID: 8052263
[TBL] [Abstract][Full Text] [Related]
6. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP
J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741
[TBL] [Abstract][Full Text] [Related]
7. Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity: cortivazol is a specific ligand for the glucocorticoid receptor.
Yoshikawa N; Makino Y; Okamoto K; Morimoto C; Makino I; Tanaka H
J Biol Chem; 2002 Feb; 277(7):5529-40. PubMed ID: 11741935
[TBL] [Abstract][Full Text] [Related]
8. Hormone-independent repression of AP-1-inducible collagenase promoter activity by glucocorticoid receptors.
Liu W; Hillmann AG; Harmon JM
Mol Cell Biol; 1995 Feb; 15(2):1005-13. PubMed ID: 7823916
[TBL] [Abstract][Full Text] [Related]
9. Analysis of intranuclear binding process of glucocorticoid receptor using fluorescence correlation spectroscopy.
Mikuni S; Tamura M; Kinjo M
FEBS Lett; 2007 Feb; 581(3):389-93. PubMed ID: 17239375
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical analysis of hormone mediated nuclear translocation of wild type and mutant glucocorticoid receptors.
Jewell CM; Webster JC; Burnstein KL; Sar M; Bodwell JE; Cidlowski JA
J Steroid Biochem Mol Biol; 1995 Nov; 55(2):135-46. PubMed ID: 7495692
[TBL] [Abstract][Full Text] [Related]
11. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
[TBL] [Abstract][Full Text] [Related]
12. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action.
Oakley RH; Jewell CM; Yudt MR; Bofetiado DM; Cidlowski JA
J Biol Chem; 1999 Sep; 274(39):27857-66. PubMed ID: 10488132
[TBL] [Abstract][Full Text] [Related]
13. Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor.
Savory JG; Hsu B; Laquian IR; Giffin W; Reich T; Haché RJ; Lefebvre YA
Mol Cell Biol; 1999 Feb; 19(2):1025-37. PubMed ID: 9891038
[TBL] [Abstract][Full Text] [Related]
14. Steroid-induced conformational changes of rat glucocorticoid receptor cause altered trypsin cleavage of the putative helix 6 in the ligand binding domain.
Xu M; Modarress KJ; Meeker JE; Simons SS
Mol Cell Endocrinol; 1999 Sep; 155(1-2):85-100. PubMed ID: 10580842
[TBL] [Abstract][Full Text] [Related]
15. Diffusion analysis of glucocorticoid receptor and antagonist effect in living cell nucleus.
Mikuni S; Pack C; Tamura M; Kinjo M
Exp Mol Pathol; 2007 Apr; 82(2):163-8. PubMed ID: 17274977
[TBL] [Abstract][Full Text] [Related]
16. Molecular identification and characterization of a and b forms of the glucocorticoid receptor.
Yudt MR; Cidlowski JA
Mol Endocrinol; 2001 Jul; 15(7):1093-103. PubMed ID: 11435610
[TBL] [Abstract][Full Text] [Related]
17. Identification of the functional domain of glucocorticoid receptor involved in RU486 antagonism.
Lee MS; Choi HS; Kwon SH; Morita K; Her S
J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):67-73. PubMed ID: 19635558
[TBL] [Abstract][Full Text] [Related]
18. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype.
Charmandari E; Kino T; Souvatzoglou E; Vottero A; Bhattacharyya N; Chrousos GP
J Clin Endocrinol Metab; 2004 Apr; 89(4):1939-49. PubMed ID: 15070967
[TBL] [Abstract][Full Text] [Related]
19. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking.
Deroo BJ; Rentsch C; Sampath S; Young J; DeFranco DB; Archer TK
Mol Cell Biol; 2002 Jun; 22(12):4113-23. PubMed ID: 12024025
[TBL] [Abstract][Full Text] [Related]
20. Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants.
Medh RD; Lay RH; Schmidt TJ
Mol Cell Endocrinol; 1998 Mar; 138(1-2):11-23. PubMed ID: 9685211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
